<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="The catalytic (primary) site, which also binds inhibitors such as" exact="oseltamivir" post="carboxylate, is responsible for cleaving the sialic acid linkages"/>
 <result pre="various ligands suggested that both endogenous substrates and the drug" exact="oseltamivir" post="carboxylate bind faster to the 2° site than the"/>
 <result pre="are homologous to those within 5 Å of the crystallographic" exact="oseltamivir" post="carboxylate from the 2HU4 structure.12 PCA details, including indices"/>
 <result pre="suggest may play a role in the molecular mechanisms of" exact="oseltamivir" post="resistance,13 are also relatively flexible in the apo state."/>
 <result pre="allow negatively charged small molecules such as sialic acid or" exact="oseltamivir" post="carboxylate to move from the 2° site to the"/>
 <result pre="suggested electrostatic funneling as being the main driving force for" exact="oseltamivir" post="carboxylate association to the active site. Chloride anion and"/>
 <result pre="Structure-based design and synthesis of C-1- and C-4-modified analogs of" exact="zanamivir" post="as neuraminidase inhibitors. J. Med. Chem.2013, 56, 671–684. 10.1021/jm3009713.23330908"/>
 <result pre="Chem.2013, 56, 671–684. 10.1021/jm3009713.23330908 WenW. H.; et al. Analogs of" exact="zanamivir" post="with modified C4-substituents as the inhibitors against the group-1"/>
</results>
